Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use SKYCLARYS safely and effectively. See full prescribing information for SKYCLARYS. SKYCLARYS® (omaveloxolone) capsules, for oral useInitial U.S. Approval: 2023
Medication labelWhy this: Advisory · dailymed-prescription
SKYCLARYS is indicated for the treatment of Friedreich's ataxia in adults and adolescents aged 16 years and older.
- generic_name
- omaveloxolone
- product_names
- omaveloxolone
- ndc
- 64406-250, 64406-250-90
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en